163617-76-3

Upstream product

• 163617-75-2 2,4-dioxo-5-(4-methoxyphenyl)methyl-1-(3-methyl-1-butyl)-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 163617-74-1 N-(4-methoxyphenyl)methyl-N'-(3-methyl-1-butyl)-1,2-phenylenediamine 

Downstream Products

• 163617-78-5 N-[2,4-dioxo-1-(3-methyl-1-butyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-phenylurea 
• 163617-79-6 N-[2,4-dioxo-1-(3-methyl-1-butyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-methoxyphenyl)urea 
• 163618-23-3 N-[5-(2-dimethylaminoethyl)-2,4-dioxo-1-(3-methyl-1-butyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-phenylurea 
• 163618-26-6 N-[5-(2-diethylaminoethyl)-2,4-dioxo-1-(3-methyl-1-butyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-phenylurea 
• 163618-41-5 N-[5-(2-dimethylaminoethyl)-2,4-dioxo-1-(3-methyl-1-butyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-methoxyphenyl)urea 
• 163618-24-4 N-[2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(n-morpholino)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-methoxyphenyl)urea 

Relevant academic research and scientific papers

Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5- benzodiazepines as cholecystokinin-2 receptor antagonists

This article deals with the synthesis and the activities of some 1,5-dialkyl-3-arylureido-1,5-benzodiazepin-2,4-diones which were prepared as potential CCK2 antagonists, with the intention to find a possible follow up of our lead compound GV150013, showin